Erratum for the research article: Genomic proling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance (Science Translational Medicine DOI: 10.1126/scitranslmed.aai7993)

J. M. Giltnane, K. E. Hutchinson, T. P. Stricker, L. Formisano, C. D. Young, M. V. Estrada, M. J. Nixon, L. Du, V. Sanchez, P. G. Ericsson, M. G. Kuba, M. E. Sanders, X. J. Mu, E. M. Van Allen, N. Wagle, I. A. Mayer, V. Abramson, H. Gόmez, M. Rizzo, W. ToyS. Chandarlapaty, E. L. Mayer, J. Christiansen, D. Murphy, K. Fitzgerald, K. Wang, J. S. Ross, V. A. Miller, P. J. Stephens, R. Yelensky, L. Garraway, Y. Shyr, I. Meszoely, J. M. Balko, C. L. Arteaga

Research output: Contribution to journalComment/debatepeer-review

Abstract

In the Research Article Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance,” the authors have provided additional competing interests, and the competing interests statements have been updated. The PDF and HTML (full text) have been corrected.

Original languageEnglish
Article numbereaaw7620
JournalScience translational medicine
Volume11
Issue number479
DOIs
Publication statusPublished - 2019 Feb 13

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Erratum for the research article: Genomic proling of ER<sup>+</sup> breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance (Science Translational Medicine DOI: 10.1126/scitranslmed.aai7993)'. Together they form a unique fingerprint.

Cite this